Oral Insulin Therapy to Prevent Progression of Immune-Mediated (Type 1) Diabetes-Reference-Cited by-同舟云学术

Oral Insulin Therapy to Prevent Progression of Immune-Mediated (Type 1) Diabetes

Published:2004-12 Issue:1 Volume:1029 Page:260-277
ISSN:0077-8923
Container-title:Annals of the New York Academy of Sciences
language:en
Short-container-title:

Author:

ERGUN-LONGMIRE BERRIN,MARKER JOHN,ZEIDLER ADINA,RAPAPORT ROBERT,RASKIN PHILIP,BODE BRUCE,SCHATZ DESMOND,VARGAS ALFONSO,ROGERS DOUGLAS,SCHWARTZ SHERWYN,MALONE JOHN,KRISCHER JEFFREY,MACLAREN NOEL K.

Publisher

Wiley

Subject

History and Philosophy of Science,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1196/annals.1309.057/fullpdf

Reference28 articles.

1. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

2. The autoimmunity of immune mediated diabetes;Kukreja;J. Clin. Endocrinol. Metab.,1999

3. 3Maclaren, N.K. & A. Kukreja. 2000. Type 1 diabetes. In The Metabolic and Molecular Bases of Inherited Disease. William S. Sly, Ed.: 1471-1478. McGraw-Hill. St. Louis.

4. Non-ophthalmologic findings of the diabetes control and complications trial;Saudek;Surv. Ophthalmol.,1995

5. Effect of intensive therapy on residual beta cell function in patients with Type-1 diabetes in the Diabetes Control and Complications Trial;Diabetes Control and Complications Trial Research Group;Ann. Intern. Med.,1998

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translation of cell therapies to treat autoimmune disorders;Advanced Drug Delivery Reviews;2024-02

2. Disease-modifying therapies and features linked to treatment response in type 1 diabetes prevention: a systematic review;Communications Medicine;2023-10-05

3. Type 1 Diabetes Prevention: a systematic review of studies testing disease-modifying therapies and features linked to treatment response;2023-04-17

4. Efficacy and safety of oral insulin versus placebo for patients with diabetes mellitus;Indian Journal of Pharmacology;2022-07

5. Targeting Lymphoid Tissues to Promote Immune Tolerance;Advanced Therapeutics;2021-04-30